Evotec SE

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40002281

Informations générales

Localisation

Germany

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

31/10/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2032

Statut

Targets set

Classification

1.5°C

Année cible

2032

Progression vers l'objectif65%
2015 (année de référence)2032
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon 2045

Statut

Targets set

Classification

1.5°C

Année cible

2045

Progression vers l'objectif37%
2015 (année de référence)2045
Description complète des objectifs

Overall Net-Zero Target: Evotec SE commits to reach net-zero greenhouse gas emissions across the value chain by 2045. Near-Term Targets: Evotec SE commits to reduce absolute scope 1 and 2 GHG emissions 50.4% by 2032 from a 2021 base year. Evotec SE also commits to increase active annual sourcing of renewable electricity from 25% in 2021 to 100% by 2026, and to continue active annual sourcing of 100% renewable electricity through 2030. Evotec SE commits to reduce scope 3 GHG from purchased goods and services and capital goods 72% per million EUR value added by 2032 from a 2021 base year. Evotec also commits that 80% of its suppliers by emissions covering purchased goods and services and capital goods will have science-based targets by 2027. Long-Term Targets: Evotec SE commits to reduce absolute scope 1 and 2 GHG emissions 95% by 2045 from a 2021 base year. Evotec SE also commits to reduce scope 3 GHG emissions by 97% per million EUR value added within the same timeframe.

Net-Zero

Statut

Targets set

Année cible

2045

Progression37%
Business Ambition 1.5°C

Statut

BA1.5 member

Date d'engagement

07/01/2021

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

DE0005664809

LEI

529900F9KI6OYITO9B12

Source : Science Based Targets initiative | Données publiques